Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

ONIVYDE

IPSEN BIOPHARMACEUTICALS CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is ONIVYDE discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that ONIVYDE 4.3MG has been permanently discontinued (last updated April 9, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is ONIVYDE not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file4 products
Affected strength4.3MG
Last updated2026-04-09

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

CAMPTOSAR

PFIZER CANADA ULC

20MG · DIN 02231622

Different strengthDifferent dosage formSame routeNo current shortage

IRINOTECAN HYDROCHLORIDE TRIHYDRATE INJECTION

SANDOZ CANADA INCORPORATED

20MG · DIN 02305143

Different strengthDifferent dosage formSame routeNo current shortage

IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR INJECTION

FRESENIUS KABI CANADA LTD

20MG · DIN 02345080

Different strengthDifferent dosage formSame routeNo current shortage

IRINOTECAN HYDROCHLORIDE INJECTION, USP

GENERIC MEDICAL PARTNERS INC

20MG · DIN 02452421

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02467135

Strength

4.3MG

Dosage Form

SUSPENSION

Route

INTRAVENOUS

Active Ingredient

IRINOTECAN

See all IRINOTECAN products →

Shortage History